欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号EE/H/0135/002
药品名称Rabeprazole Actavis
活性成分
    • rabeprazole sodium salt 20.0 mg
剂型Gastro-resistant tablet
上市许可持有人Splitting procedure: new split procedure numbers are: UK/H/6763/001-002 and PT/H/1887/001-002 Teva B.V. Swensweg 5 Haarlem 2031 GA Netherlands
参考成员国 - 产品名称Estonia (EE)
Rabeprazole Actavis
互认成员国 - 产品名称
    • Iceland (IS)
    • Lithuania (LT)
      Rabeprazole Actavis 20 mg skrandyje neirios tabletės
    • Hungary (HU)
      ACILESOL 20 mg gyomornedv-ellenálló tabletta
    • Bulgaria (BG)
      Acilesol
许可日期2010/06/14
最近更新日期2023/12/06
药物ATC编码
    • A02BC04 rabeprazole
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase